Sarah Adkins Joins Immersion Medical as Vice President of Marketing

Immersion Corporation (NASDAQ: IMMR), the leading developer and licensor of touch feedback technology (http://www.immersion.com/corporate/), announced today that Sarah Adkins has been named vice president of marketing for Immersion Medical.

"Our growth plans for Medical make Sarah an excellent fit for this pivotal position,” said Clent Richardson, Immersion president and CEO. "They include developing and deploying innovative new products and services for key markets around the world. She will also be central to our bringing together opinion leaders, medical societies, insurance companies, regulators, and other constituents to widely expand the use of medical and surgical simulators as well as dramatically improve healthcare education and training.”

Adkins has nearly 20 years’ experience as a marketing professional in the healthcare industry, with a proven track record of driving revenue growth through strategic positioning, new business development, branding, product innovation, and integrated communications. Prior to joining Immersion Medical, she was most recently strategic marketing manager for Cook Medical, a global medical device company, where she was instrumental in growing international market share. Along with many other notable positions in the healthcare field, Adkins has served as co-chair of the Corporate Member Council of the American Society of Reproductive Medicine, as a member of the Corporate Council for the American College of Obstetricians and Gynecologists and as a corporate delegate to the Society of Women’s Health Research.

"Patients, doctors, and hospitals all benefit from virtual reality medical simulation education and training. The use of our realistic medical simulators improves patient safety, provides more cost effective and efficient training, and speeds adoption of innovative medical devices and minimally invasive procedures,” said Adkins. "My focus is on introducing new market-leading products and services, localizing them for key geographies, as well as expanding marketing efforts to exploit our tremendous growth opportunity for Immersion Medical.”

About Immersion Medical, Inc. (www.immersionmedical.com)

Immersion Medical, Inc. designs, manufactures, and markets computer-based surgical simulation training systems (http://www.immersion.com/medical/surgical_sim.php) worldwide. The medical and surgical simulators integrate proprietary computer software and tactile feedback robotics to create highly realistic medical simulations that help train clinicians. The company's key product lines are the Virtual IV system, Endoscopy AccuTouch® simulator, CathLabVR™ surgical simulator, and LaparoscopyVR™ surgical simulation system.

About Immersion (www.immersion.com)

Founded in 1993, Immersion Corporation is the recognized leader in developing, licensing, and marketing digital touch technology and products. Using Immersion’s advanced touch feedback technology (http://www.immersion.com/corporate), electronic user interfaces are more compelling, entertaining, and in many applications, safer and more productive. Immersion’s technology has helped manufacturers develop innovative and creative solutions for products such as hundreds of video games and leading video console gaming systems, medical training simulators installed around the world, driver controls for automotive manufacturers, and mobile phones, such as those from LG and Samsung. Immersion’s patent portfolio includes over 700 issued or pending patents in the U.S. and other countries.

Forward-looking Statements

This press release contains "forward-looking statements” that involve risks and uncertainties, as well as assumptions that, if they never materialize or prove incorrect, could cause the results of Immersion Corporation and its consolidated subsidiaries to differ materially from those expressed or implied by such forward-looking statements.

All statements, other than the statements of historical fact, are statements that may be deemed forward-looking statements, including any projections of earnings, revenues, or other financial matters; any statements of the plans, strategies, and objectives of management for future operations; any statements concerning consumer or market acceptance of simulator products for medical training, continuing education or evaluation or consumer and market acceptance of force feedback products in general; any statements regarding proposed products or services or future economic conditions or performance; statements of belief; and any statement or assumptions underlying any of the foregoing. Immersion’s actual results might differ materially from those stated or implied by such forward-looking statements due to risks and uncertainties associated with our business, which include, but are not limited to, delay in or failure to achieve commercial demand for our products or a delay in or failure to achieve the acceptance of force feedback as a critical user experience.

For a more detailed discussion of these factors, and other factors that could cause actual results to vary materially, interested parties should review the risk factors listed in our most current Form 10-Q, which is on file with the U.S. Securities and Exchange Commission. The forward-looking statements in this press release reflect our beliefs and predictions as of the date of this release. We disclaim any obligation to update these forward-looking statements as a result of financial, business, or any other developments occurring after the date of this release.

Immersion, the Immersion logo, and AccuTouch, CathLabVR, and LaparoscopyVR are trademarks of Immersion Corporation in the United States and other countries. All other trademarks are the property of their respective owners.